ARCHIVES

USC Opts for Its own IL-2 Protocol, Shuns NCI Trial

This article is from The Cancer Letter archive.

Vol. 13 No. 19 | May 8, 1987

Download PDF Visit The Full Archive

Related Articles

Gilotrif Increases PFS Compared to Erlotinib In LUX-Lung 8 Phase III Head-to-Head Trial

October 31, 2014

Columbus CCP Forms New Entity to Administer CCOP

July 20, 1990

To Wage New War On Cancer, Advocates Plan A Campaign Inspired By Earth Day

October 31, 1997

FDA Approves New Toxicology Protocol; Drug Program Under Fire; DCT Board Approves Cutbacks, Contract Concepts

October 9, 1981

In Brief: Norman Sharpless Named Director of UNC Lineberger

September 6, 2013

Evidence Too Weak to Link Agent Orange, Cancer, IOM Says

March 22, 2002